JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoyt, K. R.
Right arrow Articles by Reynolds, I. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoyt, K. R.
Right arrow Articles by Reynolds, I. J.

Vol. 293, Issue 2, 480-486, May 2000

Inhibition of Glutamate-Induced Mitochondrial Depolarization by Tamoxifen in Cultured Neurons1

Kari R. Hoyt2 , Beth Ann McLaughlin, Donald S. Higgins, Jr. and Ian J. Reynolds3

Departments of Pharmacology (K.R.H, I.J.R.) and Neurobiology (B.A.M.), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; and Department of Neurology (D.S.H.), The Ohio State University College of Medicine, Columbus, Ohio

In central neurons, glutamate receptor activation causes massive calcium influx and induces a mitochondrial depolarization, which is partially blocked by cyclosporin A, suggesting a possible activation of the mitochondrial permeability transition pore (PTP) as a mechanism. It has been recently reported that tamoxifen (an antiestrogen chemotherapeutic agent) blocks the PTP in isolated liver mitochondria, similar to cyclosporin A. In this study, we tested whether tamoxifen inhibits the mitochondrial depolarization induced by glutamate receptor activation in intact cultured neurons loaded with the fluorescent dye 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide. This dye reports disruptions in mitochondrial membrane potential, which can be caused by PTP activation. We found that glutamate (100 µM for 10 min) causes a robust mitochondrial depolarization that is partially inhibited by tamoxifen. The maximum inhibitory concentration of tamoxifen was 0.3 µM, with concentrations higher and lower than 0.3 µM being less effective. However, although tamoxifen (0.3 µM) blocked glutamate-induced mitochondrial depolarization, it did not inhibit glutamate-induced neuronal death, in contrast to the PTP inhibitor cyclosporin A. A relatively high concentration of tamoxifen (100 µM) caused mitochondrial depolarization itself and was neurotoxic. These data suggest that tamoxifen may be an inhibitor of the PTP in intact neurons. However, the lack of specificity of most PTP inhibitors, and the difficulty in measuring PTP in intact cells, preclude definite conclusions about the role of PTP in excitotoxic injury.


1 This study was supported by DAMD17-98-1-8627 (to I.J.R.), the American Heart Association (to I.J.R.), AG 00751 (to D.S.H.), NS 07391 (to B.A.M.), and NS 07291 (to K.R.H.).

2 Current address: Department of Neurology, 190 Medical Research Facility, 420 West 12th Ave., The Ohio State University, Columbus, OH 43210. E-mail: hoyt.31{at}osu.edu

3 I.J.R. is an Established Investigator of the American Heart Association.


0022-3565/00/2932-0480$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
JEMHome page
I. G. Stavrovskaya, M. V. Narayanan, W. Zhang, B. F. Krasnikov, J. Heemskerk, S. S. Young, J. P. Blass, A. M. Brown, M. F. Beal, R. M. Friedlander, et al.
Clinically Approved Heterocyclics Act on a Mitochondrial Target and Reduce Stroke-induced Pathology
J. Exp. Med., July 19, 2004; 200(2): 211 - 222.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.